Xanadu Bio

Xanadu Bio

Biotechnology, 5801 S Ellis Ave Ste 1, Chicago, Illinois, 60637, United States, 1-10 Employees

xanadubio.com

  • LinkedIn

phone no Phone Number: +13*********

Who is XANADU BIO

Xanadu Bio is a privately held, next generation nanoparticle delivery company focusing on the delivery of mRNA and other nucleic acids that utilizes PACE platform technology. PACE technol...

Read More

map
  • 5801 S Ellis Ave Ste 1, Chicago, Illinois, 60637, United States Headquarters: 5801 S Ellis Ave Ste 1, Chicago, Illinois, 60637, United States
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Billion and Over

industries-icon Industry: Biotechnology

SIC SIC Code: 8011; 8221 | NAICS Code: 621111 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from XANADU BIO

Xanadu Bio Org Chart and Mapping

Employees

Taylor Feehley

Chief Operating Officer

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Xanadu Bio

Answer: Xanadu Bio's headquarters are located at 5801 S Ellis Ave Ste 1, Chicago, Illinois, 60637, United States

Answer: Xanadu Bio's phone number is +13*********

Answer: Xanadu Bio's official website is https://xanadubio.com

Answer: Xanadu Bio's revenue is $1 Billion and Over

Answer: Xanadu Bio's SIC: 8011; 8221

Answer: Xanadu Bio's NAICS: 621111

Answer: Xanadu Bio has 1-10 employees

Answer: Xanadu Bio is in Biotechnology

Answer: Xanadu Bio contact info: Phone number: +13********* Website: https://xanadubio.com

Answer: Xanadu Bio is a privately held, next generation nanoparticle delivery company focusing on the delivery of mRNA and other nucleic acids that utilizes PACE platform technology. PACE technology is a next-generation polymeric nanoparticle that consists of three monomers that are fully biodegradable, and allows for efficient delivery of and protection from nuclease degradation for different types of nucleic acids, including mRNA. PACE is easily manufactured, cost effective, scalable and can be functionalized to allow both organ and cell specific delivery of its nucleic acid payload. PACE is formulated and optimized to allow safe delivery either systemically or intranasally. Leveraging PACE, Xanadu is initially focused on developing nasal vaccine boosters for the prevention and treatment of SARS CoV-2 infection and for other indications.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access